InvestorsHub Logo
Followers 100
Posts 11038
Boards Moderated 1
Alias Born 06/14/2013

Re: None

Tuesday, 03/15/2016 3:10:02 PM

Tuesday, March 15, 2016 3:10:02 PM

Post# of 26907

Excellent Comments By Doctor Ken on Spectra


DoctorKen Friday, 03/11/16 03:02:07 PM
Re: None
Post # of 7506

First time poster, but I’ve been following SCIE and this board for several months now. I’ve found a lot of useful information here, so I decided to pay it forward and offer my own perspective.

First, as a physician, I can tell you the WavStat product is the real deal - literally a game changer in the medical industry. The potential applications go far beyond diagnosing colorectal cancer. Our recent acquisition of Oncoscope now adds the capability to diagnosis Barret’s Esophagus (precancerous), and with further development I can easily see this same technology being used to diagnose cancers of the skin, cervix, bladder, and more. And the WavStat technology works! I’ve reviewed the clinical studies with a skeptical eye and the evidence is there to back it up. I’ve shown this to other physicians, including Gastroenterologists, who are excited to add it to their practice. Many have invested in SCIE themselves. This product will save time and money, reduce complications from physical biopsies, and ultimately save lives. I believe within 2-3 years this will be the standard of care for colonoscopies and beyond.

Secondly, as an investor, I’m into this for 15,000,000 at an average price of 0.002. I’m adding more at these levels. I love a quick profit as much as anyone, but please don’t be tempted to flip at these levels. SCIE is a real gem. It’s not often you find a company with a working, high-value product – in a multibillion dollar industry – for less than a penny. In my opinion, their 33 patents alone should give SCIE a PPS of 0.04-0.05, even fully diluted. I for one am holding long for a potential buyout in the $500M to $1B range. Do the math. It’s going to be a fun ride.